Monday, March 31, 2014

Reuters: Health News: GSK pulls bid to extend use of kidney drug to ovarian cancer

GSK pulls bid to extend use of kidney drug to ovarian cancer

LONDON (Reuters) - GlaxoSmithKline on Monday withdrew an application to use Votrient, a drug licensed for kidney cancer, to treat advanced ovarian can...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/TUbGLXjmD3A/story01.htm

No comments:

Post a Comment

Subscribe Now: Feed Icon